ImmuCell Corp. (ICCC)
-NasdaqCM 3.65 
0.05(1.35%) 1:20PM EDT
| Prev Close: | 3.70 |
|---|
| Open: | 3.65 |
|---|
| Bid: | 1.00 x 200 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 0.1 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 3.65 - 3.66 |
|---|
| 52wk Range: | 3.25 - 7.00 |
|---|
| Volume: | 540 |
|---|
| Avg Vol (3m): | 2,428 |
|---|
| Market Cap: | 11.02M |
|---|
| P/E (ttm): | 79.35 |
|---|
| EPS (ttm): | 0.05 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- IMMUCELL CORP /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Thu, Jun 13)
- IMMUCELL CORP /DE/ FinancialsEDGAR Online Financials(Fri, May 17)
- ImmuCell Announces Increase in Product Sales and Continued ProfitabilityMarketwired(Tue, May 14)
- IMMUCELL CORP /DE/ Files SEC form 8-K, Financial Statements and ExhibitsEDGAR Online(Tue, May 14)
- IMMUCELL CORP /DE/ Files SEC form 10-K, Annual ReportEDGAR Online(Thu, Mar 28)
- Cattle-focused biotech ImmuCell sees growth in tough dairy yearat bizjournals.com(Thu, Feb 14)
- IMMUCELL CORP /DE/ Files SEC form 8-K, Financial Statements and ExhibitsEDGAR Online(Thu, Feb 14)
- ImmuCell Announces Product Sales Increases and Other Financial ResultsMarketwired(Thu, Feb 14)
- IMMUCELL CORP /DE/ Files SEC form 10-Q/A, Quarterly ReportEDGAR Online(Tue, Jan 8)
- IMMUCELL CORP /DE/ Files SEC form 10-K/A, Annual ReportEDGAR Online(Tue, Jan 8)
- IMMUCELL CORP /DE/ Files SEC form 10-Q, Quarterly ReportEDGAR Online(Tue, Nov 13)
- IMMUCELL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Wed, Nov 7)
- ImmuCell Announces Product Sales Increases and Other Financial ResultsMarketwired(Wed, Nov 7)
- IMMUCELL CORP /DE/ Files SEC form 8-K, Financial Statements and ExhibitsEDGAR Online(Tue, Aug 28)
- ImmuCell Presents Strategic Business Overview at Investment ForumMarketwired(Tue, Aug 28)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 2.02 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
ImmuCell Corporation engages in the acquisition, development, manufacture, and sale of products that enhance the health and productivity of cows for the dairy and beef industries in the United States and internationally.
View More